SNCA and Parkinson disease: In newly diagnosed PD, characterized by alpha‐synuclein pathology as a central feature, GCase dysfunction may predominantly contribute to cognitive decline due to its direct involvement in alpha‐synuclein metabolism.37, 38, 39